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distances (5 versus 10 mm), and different radionuclides, i.e. Cobalt-60 (60Co) and 192Ir, by delivering a 
total treatment dose of 32 Gy to the left breast. Absorbed doses to the OARs (e.g. left lung, heart, right 
breast, spleen, etc.) were then evaluated. A maximum left lung dose of 1.5 Gy was recorded, while doses 
to the other OARs were all below 1 Gy. The treatment using dual plane catheter arrangement contributed 
to a slightly higher dose to the OARs, despite equal dose to the breast. There was no dose difference 
between different inter-dwell distances used in this study. 60Co resulted in a slightly higher left lung dose 
than that of 192Ir, while the results were the opposite for the other OARs. HDR brachytherapy allows high 
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Abstract. This study aimed to evaluate the absorbed doses received by the organs at risk 
(OARs) following Iridium-192 (192Ir) high dose rate (HDR) brachytherapy of the left breast. 
The MIRD5 adult female anthropomorphic phantom, readily available in the Geant4 Monte 
Carlo package was used. However, the left breast was modified from 195 to 145 cm3, to 
represent a breast following lumpectomy. Left breast was chosen due to its higher cancer 
occurrence than the right breast. The HDR sources were constructed with an outer cylindrical 
dimension of 4.5 mm (length) × 0.9 mm (diameter). Various influencing parameters were 
studied, i.e. catheter arrangement (single versus dual plane), source inter-dwell distances (5 
versus 10 mm), and different radionuclides, i.e. Cobalt-60 (60Co) and 192Ir, by delivering a total 
treatment dose of 32 Gy to the left breast. Absorbed doses to the OARs (e.g. left lung, heart, 
right breast, spleen, etc.) were then evaluated. A maximum left lung dose of 1.5 Gy was 
recorded, while doses to the other OARs were all below 1 Gy. The treatment using dual plane 
catheter arrangement contributed to a slightly higher dose to the OARs, despite equal dose to 
the breast. There was no dose difference between different inter-dwell distances used in this 
study. 60Co resulted in a slightly higher left lung dose than that of 192Ir, while the results were 
the opposite for the other OARs. HDR brachytherapy allows high dose to be delivered to the 
breast within a short period of time, with minimal absorbed doses to the OARs. 
1.  Introduction 
Breast cancer is the world’s most common cancer involving women [1], with more than 1 million 
incidences in 2002 and more than 400,000 deaths worldwide [2]. The standard of care for breast 
cancer treatment includes surgical removal of the tumor and adjuvant therapies, i.e. local irradiation 
with systemic therapies (e.g. biological agents, hormonal therapies and chemotherapy) [3]. 
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High dose rate (HDR) interstitial brachytherapy has been investigated in selected patients as a 
potential single radiotherapy technique, i.e. partial breast irradiation, following tumorectomy or 
lumpectomy [4], with the idea to minimize morbidity, optimize the treatment plan and maintain the 
treatment outcomes. Commonly used radionuclides include, Iridium-192 (192Ir) (Ē = 0.38 MeV, half-
life, t1/2 = 73.8 d) and Cobalt-60 (60Co) (Ē = 1.25 MeV, t1/2 = 5.26 y). Similar to external beam 
radiotherapy of the breast, the main organs at risk (OARs) include the other breast, lungs and heart. 
Estimating the dose to the OARs prior to the treatment is crucial, so a well-planned treatment can be 
delivered, and overexposure to the OARs can be avoided. Nonetheless, direct dose measurement of the 
OARs involve further unnecessary surgical procedure, hence, is not a feasible and recommended 
technique. 
Geant4 is one of the latest Monte Carlo (MC) code packages that provides accurate probability 
estimation of radiation events. It allows flexible manipulation of the geometry, for various medical 
physics researches. In this study, the absorbed dose received by the OARs following HDR treatment 
on the left breast was assessed using the Geant4 MC simulation. This was done by estimating the 
absorbed dose using different catheter arrangements, source inter-dwell distances and radionuclides. 
2.  Methodology 
2.1.  The MIRD5 phantom 
The study was performed using Geant4.9.6.p03 [5, 6] advanced example human_phantom. The 
phantom was adopted from MIRD Pamphlet 5, with height and weight of 174 cm and 70 kg, 
respectively [7]. Female phantom equipped with both breasts (each with a volume of 194 cm3) was 
selected [8]. However in this study, the left breast volume was reduced to 145 cm3, to represent a 
breast following lumpectomy, as in Figure 1. The left breast was chosen due to its higher cancer 
occurrence than the right breast [9]. 
(a)  (b)  (c) (d)  
Figure 1. The phantom’s left breast before ((a) anterior and (b) superior views) and after ((c) anterior and (d) 
superior views) lumpectomy. 
2.2.  The 192Ir sealed source 
The MicroSelectron HDR (Nucletron®, Elekta, Stockholm, Sweden) 192Ir source was simulated [10]. 
The 3.6 mm (length, l) × 0.65 mm (diameter, d) cylindrical 192Ir core (22.42 g.cm-3) encapsulated with 
4.5 mm (l) × 0.9 mm (d) stainless steel (8.02 g.cm-3) was modeled as in Figure 2. 
 
Figure 2. The microSelectron HDR 192Ir source as modeled using the Geant4 package. 
2.3.  Difference in treatment techniques 
A dose of 32 Gy was prescribed to the left breast. Four different treatment techniques were studied, 
i.e. single and dual plane catheter arrangements, each with 5 and 10 mm inter-dwell distances. The 
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most peripherally located sealed source was kept at a minimum of 10 to 15 mm from the skin, to limit 
the skin dose and ensure that the radiation is contained within the breast volume.  
 For every technique used, 107 disintegrations were generated and repeated three times, to obtain a 
standard deviation of less than 1 %. The mean energy (MeV) deposited to each OARs was normalized 
to the energy deposited to the left breast. These normalized values were used to obtain the dose to all 
the OARs, by multiplying the values with the dose prescribed to the left breast, i.e. 32 Gy. 
All simulations were later repeated by changing the 192Ir to 60Co, using similar source geometry. 
The decay of these radionuclides was modeled by utilising the Geant4 Radioactive Decay component. 
Low Energy Electromagnetic Package [11], based on the Livermore Evaluated Data Libraries was 
adopted to model the electromagnetic interactions of photons and electrons. The threshold of 
production of secondary particles was fixed to 1 mm. 
2.3.1.  Single plane catheter arrangement with 5 and 10 mm inter-dwell distances. For single plane 
arrangement, 5 catheters were placed in parallel across the center of the breast volume, with a 
separation of 15 mm between each other. The inter-dwell distances between each source’s stopping 
point was set to 5 mm (Figure 3a). The simulation was later repeated by changing the inter-dwell 
distance to 10 mm (Figure 3b).  
(a)       (b)  
Figure 3. The anterior-superior view of the left breast for single plane catheter arrangement with (a) 5 and (b) 10 
mm inter-dwell distances, as modeled using the Geant4 package. 
2.3.2.  Dual plane catheter arrangement with 5 and 10 mm inter-dwell distances. For dual plane 
arrangement, a total of 10 catheters were placed in parallel across the breast volume (5 catheters to 
each plane, i.e. superficial and deep), with a separation of 14 mm between each plane. Similar to the 
single plane technique, a separation of 15 mm was applied between each catheter of similar plane. The 
inter-dwell distances between each source’s stopping point was set to 5 mm (Figure 4a). The 
simulation was later repeated by changing the inter-dwell distances to 10 mm (Figure 4b). 
 
(a)       (b)  
Figure 4. The anterior-superior view of the left breast for dual plane catheter arrangement with (a) 5 and (b) 10 
mm inter-dwell distances, as modeled using the Geant4 package. 
AOCMP-SEACOMP










3.  Results & Discussions 
The left breast volume was reduced from the initial value, to represent the breast following 
lumpectomy (breast conserving surgery). Two different radionuclides were used in this study, i.e. 192Ir 
and 60Co. Both radionuclides have different types and energies of decay emissions. The simulations 
were carried out for four different treatment techniques, i.e. single and dual planes, each with 5 and 10 
mm inter-dwell distances. 
 




Figure 6. The absorbed dose to OARs with different treatment techniques using the 60Co source. 
 
AOCMP-SEACOMP










From this study, it was found that 192Ir and 60Co deliver nearly the same absorbed dose to the 
OARs, while delivering similar prescribed dose to the left breast. Based on Figure 5 and 6, the 
absorbed dose delivered to the OARs by 60Co were found to be slightly higher compared to 192Ir, 
except for the left lung, where the dose was higher when 192Ir was being used. This may be due to 
different decays of the two radionuclides. As 60Co emits higher gamma energy (1.17 MeV) than 192Ir 
(0.32 MeV), the organs that are located further from the left breast received higher absorbed dose 
when 60Co is being used. However, since the beta energy of 192Ir (0.67 MeV) is higher than 60Co (0.32 
MeV), a significant portion of the emitted beta particles managed to escape the left breast and deposit 
their energy into the left lung, compared to 60Co, where most of the beta particles were absorbed by 
the left breast. These findings are in agreement with previous studies that compared the dose to OARs 
from 60Co and 192Ir sources [12], as well as the effect of various distances between these sources and 
the OARs [13]. 
The dual plane treatment technique delivers significantly higher absorbed dose to the OARs 
compared to the single plane technique, i.e. 1.54 and 1.38 Gy, respectively, for the left lung, and 0.78 
and 0.70 Gy, respectively, for the heart. Thus, absorbed dose reduction of 9.9 % to the left lung and 
10.5 % to the heart can be made, when the single plane treatment technique is being used.  
There was no significant difference between the absorbed dose received by the OARs for 5 and 10 
mm inter-dwell distances. This can be seen in both the single and dual plane treatment techniques. 
This finding may be due to the small difference between the inter-dwell distances (only 5 mm). 
4.  Conclusion 
Interstitial HDR brachytherapy following lumpectomy can be considered reasonably safe, as the 
absorbed dose received by the OARs were found to be significantly low (less than 1 Gy), while the 
maximum absorbed dose recorded by the left lung was only 1.5 Gy. 60Co shows better dose sparing 
effect towards the left lung compared to 192Ir. However, 192Ir delivers relatively much lower absorbed 
dose to the other OARs compared to 60Co. Our study showed that, different number of treatment plane 
can greatly affect the absorbed dose to the OARs, while the difference in the inter-dwell distances 
does not affect the absorbed dose. However, a reduction in the number of catheter arrangement or 
plane may increase the duration of the treatment, even with similar prescribed dose to the breast.  
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